Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
JAMA Intern Med. 2021 Aug 1;181(8):1100-1105. doi: 10.1001/jamainternmed.2021.3108.
Up to two-thirds of African American individuals carry the benign rs2814778-CC genotype that lowers total white blood cell (WBC) count.
To examine whether the rs2814778-CC genotype is associated with an increased likelihood of receiving a bone marrow biopsy (BMB) for an isolated low WBC count.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective genetic association study assessed African American patients younger than 90 years who underwent a BMB at Vanderbilt University Medical Center, Mount Sinai Health System, or Children's Hospital of Philadelphia from January 1, 1998, to December 31, 2020.
The rs2814778-CC genotype.
The proportion of individuals with the CC genotype who underwent BMB for an isolated low WBC count and had a normal biopsy result compared with the proportion of individuals with the CC genotype who underwent BMB for other indications and had a normal biopsy result.
Among 399 individuals who underwent a BMB (mean [SD] age, 41.8 [22.5] years, 234 [59%] female), 277 (69%) had the CC genotype. A total of 35 patients (9%) had clinical histories of isolated low WBC counts, and 364 (91%) had other histories. Of those with a clinical history of isolated low WBC count, 34 of 35 (97%) had the CC genotype vs 243 of 364 (67%) of those without a low WBC count history. Among those with the CC genotype, 33 of 34 (97%) had normal results for biopsies performed for isolated low WBC counts compared with 134 of 243 individuals (55%) with biopsies performed for other histories (P < .001).
In this genetic association study, among patients of African American race who had a BMB with a clinical history of isolated low WBC counts, the rs2814778-CC genotype was highly prevalent, and 97% of these BMBs identified no hematologic abnormality. Accounting for the rs2814778-CC genotype in clinical decision-making could avoid unnecessary BMB procedures.
多达三分之二的非裔美国人携带降低总白细胞 (WBC) 计数的良性 rs2814778-CC 基因型。
检查 rs2814778-CC 基因型是否与接受骨髓活检 (BMB) 以治疗孤立性低 WBC 计数的可能性增加相关。
设计、地点和参与者:这项回顾性遗传关联研究评估了 1998 年 1 月 1 日至 2020 年 12 月 31 日期间在范德比尔特大学医学中心、西奈山健康系统或费城儿童医院接受 BMB 的年龄在 90 岁以下的非裔美国患者。
rs2814778-CC 基因型。
与 CC 基因型患者因其他原因接受 BMB 且活检结果正常的比例相比,因孤立性低 WBC 计数接受 BMB 且活检结果正常的 CC 基因型患者的比例。
在 399 名接受 BMB 的患者中(平均[SD]年龄为 41.8[22.5]岁,234[59%]为女性),277 名(69%)为 CC 基因型。共有 35 名患者(9%)有孤立性低 WBC 计数的临床病史,364 名(91%)有其他病史。在有孤立性低 WBC 计数病史的患者中,35 名中有 34 名(97%)为 CC 基因型,而在无低 WBC 计数病史的 364 名患者中,有 243 名(67%)为 CC 基因型。在 CC 基因型患者中,34 名(97%)因孤立性低 WBC 计数接受的 BMB 活检结果正常,而 243 名(55%)因其他原因接受 BMB 活检的患者中有 134 名(55%)活检结果正常(P<0.001)。
在这项遗传关联研究中,在接受有孤立性低 WBC 计数临床病史的 BMB 的非裔美国患者中,rs2814778-CC 基因型非常普遍,其中 97%的 BMB 未发现血液异常。在临床决策中考虑 rs2814778-CC 基因型可以避免不必要的 BMB 程序。